NCT03598361

Brief Summary

Ensuring an adequate supply of nutrients, which include trace elements, is particularly important in pregnancy. Both deficiency and excess of trace elements in the body can interfere with conception and maintaining a healthy pregnancy. The effects of malnutrition and shortages in fetal life may increase the risk of miscarriages, congenital malformations, premature births, intrauterine fetal growth restriction (IUGR) and more frequent perinatal mortality. Nutritional deficiencies during fetal development may also have long-term consequences for the child, such as disorders in his biological and psychomotor development. In women of procreative age, an adequate supply of minerals, especially iron, calcium, zinc, magnesium and copper, is very important. The results of clinical trials indicate an association of anemia in pregnant women with premature delivery and low birth weight of a newborn. Calcium deficiency leads to the development of hypertension in pregnancy (including preeclampsia) and increases the risk of premature birth. Deficiency of zinc and copper in the mother's body is associated with complications of pregnancy and childbirth and affects inappropriate fetal development. The deficiency of these mineral components is often observed in young women-potential mothers. Increasing during pregnancy the need for nutrients and abnormal nutrition, intensify the deficiencies of minerals and affect the abnormal development of the fetus. It seems that during the course of pregnancy, changes in the mineral nutrition of women can be observed, which is why it is important to monitor this condition in the subsequent months of pregnancy. Due to the above, the aim of the planned research is to determine the nutrition and nutritional status of women in the subsequent trimesters of pregnancy. Obtained results will allow to formulate appropriate nutritional recommendations and / or indicate the need to implement appropriate mineral supplementation for women in every trimester of pregnancy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Mar 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Mar 2018Nov 2028

Study Start

First participant enrolled

March 20, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2028

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

9.8 years

First QC Date

July 1, 2018

Last Update Submit

March 26, 2026

Conditions

Keywords

pregnancy outcomes, minerals

Outcome Measures

Primary Outcomes (1)

  • minerals (Ca, Mg, Fe, Zn)

    measure minerals in serum, hair, amniotic fluid

    1 year

Secondary Outcomes (8)

  • maternal anthropometric parameters

    2 years

  • fetal body weight

    2 years

  • fetal head circumference

    2 years

  • fetal biparietal diameter

    2 years

  • prenatal diagnosis: PAPP-A

    2 years

  • +3 more secondary outcomes

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A group of approximately 300 women is planned to be included in the study in the first trimester of pregnancy (up to 14 weeks of pregnancy).

You may qualify if:

  • Diagnosed intrauterine pregnancy until week 14.
  • Single pregnancy without congenital malformations in ultrasound examination.
  • Lack of exponents threatening miscarriage (bleeding, lower abdominal pain, chorionic hematoma).
  • Lack of use of drugs affecting the mineral metabolism of the body.
  • Signing consent to participate in the study.

You may not qualify if:

  • Ectopic or heterotopic pregnancy.
  • Twin pregnancy (or other multiple pregnancy).
  • Obstetric load in the direction of numerous miscarriages, premature births under 34 weeks, pregnancy, fetal growth disorders (hypotrophy, macrosomia).
  • Congenital and /or genetic defects found in current pregnancy or in the patient.
  • Supply of drugs affecting the mineral metabolism of the body.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poznan University of Life Sciences

Poznan, 60-624, Poland

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood samples hair amniotic fluid

Central Study Contacts

Joanna Suliburska, Assoc. Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principial Investigator

Study Record Dates

First Submitted

July 1, 2018

First Posted

July 26, 2018

Study Start

March 20, 2018

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

November 30, 2028

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations